90 related articles for article (PubMed ID: 8547042)
1. Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial.
Kristensen JK; Petersen LJ; Hansen U; Nielsen H; Skov PS; Nielsen HJ
Br J Dermatol; 1995 Dec; 133(6):905-8. PubMed ID: 8547042
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effect of ranitidine in psoriasis. An open prospective study].
Nielsen HJ; Kristensen JK; Hansen U; Nielsen HI; Skov PS; Petersen LM
Ugeskr Laeger; 1997 Jan; 159(5):598-600. PubMed ID: 9045450
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study.
Zonneveld IM; Meinardi MM; Karlsmark T; Johansen UB; Kuiters GR; Hamminga L; Staberg B; van't Veen AJ; Bossuyt PM; van Niel JC; Bos JD
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):932-4. PubMed ID: 9204057
[TBL] [Abstract][Full Text] [Related]
4. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine.
Petersen LJ; Hansen U; Kristensen JK; Nielsen H; Skov PS; Nielsen HJ
Acta Derm Venereol; 1998 May; 78(3):190-3. PubMed ID: 9602224
[TBL] [Abstract][Full Text] [Related]
5. High-dose ranitidine is ineffective in the treatment of psoriasis.
Cetin L; Yilmaz E; Alpsoy E; Başaran E
Br J Dermatol; 1997 Dec; 137(6):1021-2. PubMed ID: 9470934
[No Abstract] [Full Text] [Related]
6. An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis.
Witkamp L; Velthuis PJ; Verhaegh ME; Hulsmans RF; Bossuyt PM; Bos JD; Meinardi MM
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):778-81. PubMed ID: 8496427
[No Abstract] [Full Text] [Related]
7. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.
Farup PG; Wetterhus S; Osnes M; Ulshagen K
Scand J Gastroenterol; 1997 Aug; 32(8):755-9. PubMed ID: 9282965
[TBL] [Abstract][Full Text] [Related]
10. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine therapy for recalcitrant warts in adults: a preliminary study.
Karaman G; Sendur N; Sevk E
J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):495-6. PubMed ID: 11763407
[No Abstract] [Full Text] [Related]
12. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
13. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
14. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
15. [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].
López-Mato A; Rovner J; Illa G; Vieitez A; Boullosa O
Vertex; 2003; 14(52):85-96. PubMed ID: 12883589
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine improves lymphocyte function after severe head injury: results of a randomized, double-blind study.
Rixen D; Livingston DH; Loder P; Denny TN
Crit Care Med; 1996 Nov; 24(11):1787-92. PubMed ID: 8917026
[TBL] [Abstract][Full Text] [Related]
17. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
19. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
[TBL] [Abstract][Full Text] [Related]
20. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]